Meanwhile, novel approaches like immune checkpoint blockades targeting programmed cell death protein 1 (PD-1) or its ligand PD-L1 have also emerged as powerful methods against tumor progression, relapse, and metastasis [29, 30]. This evidence concerns the gene PDCD1 and neoplasm.